Concepedia
6
Publications
636
Citations
H-Index
2016
Active since
Affiliations
Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)
Royal Brompton Hospital
University of Michigan
Michigan Medicine
Harvard University
Hakima Hannachi is an author at Merck & Co., Inc., Rahway, NJ, USA (United States).
Publications per year
2016–2021
Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus
Kristy Iglay, Hakima Hannachi, Patrick Joseph Howie et al. · Current Medical Research and Opinion · 2016 · 488 citations
Residual Ischemic Risk and Its Determinants in Patients With Previous Myocardial Infarction and Without Prior Stroke or <scp>TIA</scp>: Insights From the <scp>REACH</scp> Registry
Jérémie Abtan, Deepak L. Bhatt, Yedid Elbez et al. · Clinical Cardiology · 2016 · 53 citations · Full text
Geographic variation and risk factors for systemic and limb ischemic events in patients with symptomatic peripheral artery disease: Insights from the <scp>REACH</scp> Registry
Jérémie Abtan, Deepak L. Bhatt, Yedid Elbez et al. · Clinical Cardiology · 2017 · 38 citations · Full text
Ertugliflozin Compared to Other Anti-hyperglycemic Agents as Monotherapy and Add-on Therapy in Type 2 Diabetes: A Systematic Literature Review and Network Meta-Analysis
Ann McNeill, Glenn Davies, Eliza Kruger et al. · Diabetes Therapy · 2019 · 27 citations · Full text
Efficacy and Safety of Ertugliflozin in Patients with Overweight and Obesity with Type 2 Diabetes Mellitus
Steven B. Heymsfield, Annaswamy Raji, Silvina Gallo et al. · Obesity · 2020 · 18 citations · Full text
Rows per page
1–5 of 6